Search

Displaying results 6711 - 6720 of 10000 in total
  1. Drug

    Quisqualic acid

    go.drugbank.com/drugs/DB02999
    Experimental

    Quisqualic acid is an agonist at two subsets of excitatory amino acid receptors, ionotropic receptors that directly control membrane channels and metabotropic receptors that indirectly mediate calcium … The compound is obtained from the seeds and fruit of _Quisqualis chinensis_.

    Categories: Amino Acids, Peptides, and Proteins
  2. Drug

    Nurulimab

    go.drugbank.com/drugs/DB18946
    Investigational

    Nurulimab is under investigation in clinical trial NCT05732805 (A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-pd-1 Compared to Anti-pd-1 Monotherapy as First-line Treatment in

    Categories: prolgolimab and nurulimab, Antineoplastic and Immunomodulating Agents
  3. Indication

    Thyroid Carcinoma

    go.drugbank.com/conditions/DBCOND0032753
    Drugs: Iodide I-131
    Synonyms: Thyroid Ca
  4. Drug

    AGA2115

    go.drugbank.com/drugs/DB17840
    Investigational

    AGA2115 is a humanized bispecific antibody neutralizing both sclerostin and Dickkopf-1. … Developed by Angitia Biopharmaceuticals, AGA2115 is being investigated for the treatment of osteogenesis imperfect.[L46646]

  5. Target

    Epithelial discoidin domain-containing receptor 1

    go.drugbank.com/bio_entities/BE0001124
    TargetHumans

    Promotes smooth muscle cell migration, and thereby contributes to arterial wound healing. Also plays a role in tumor cell invasion. Phosphorylates PTPN11 … , survival and cell proliferation.

    Synonyms: CAK, Tyrosine-protein kinase CAK
  6. Drug

    Nicaraven

    go.drugbank.com/drugs/DB06397
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    E-2012

    go.drugbank.com/drugs/DB05171
    Experimental

    E-2012 is a gamma secretase modulator that is being evaluated as a potential new treatment for Alzheimer's disease.

    Categories: Gamma Secretase Inhibitors and Modulators
  8. Drug

    Tanaproget

    go.drugbank.com/drugs/DB04787
    Experimental

    Tanaproget (NSP-989) is an investigational non-steroidal progestin. … An analog of tanaproget, 4-fluoropropyltanaproget (18F), has been developed as a radiotracer for imaging of the PR in positron emission tomography.

  9. Drug

    Altropane I-123

    go.drugbank.com/drugs/DB15144
    Investigational

    Altropane I-123 is under investigation in clinical trial NCT01950468 (A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the

    Synonyms: Altropane I-123
  10. Drug

    Licofelone

    go.drugbank.com/drugs/DB04725
    Experimental

    Developed by the German pharmaceutical company, Merckle GmbH, together with EuroAlliance partners Alfa Wassermann and Lacer, licofelone (ML3000) is a dual COX/LOX inhibitor and the first member of this … new class of analgesic and anti-inflammatory drugs.